{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:39:57Z","timestamp":1792291197096,"version":"4.4.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jacc.2024.05.081","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T15:01:57Z","timestamp":1727103717000},"page":"1342-1362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Implantable Cardioverter Defibrillator and\u00a0Resynchronization Therapy in\u00a0Patients With Overt Chronic Kidney\u00a0Disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Cecilia R.","family":"Varga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Leyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5055-8112","authenticated-orcid":false,"given":"Parta","family":"Hatamizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jacc.2024.05.081_bib1","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib2","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.05.081_bib3","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.05.081_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2024.05.081_bib5","first-page":"455","article-title":"Cardiorenal syndrome: an important subject in nephrocardiology","volume":"39","author":"Hatamizadeh","year":"2021","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jacc.2024.05.081_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcm.2024.03.002","article-title":"From cardiorenal syndrome to nephrocardiology: the journey of exploring the interconnection between nephrology and cardiovascular medicine","author":"Hatamizadeh","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2215\/CJN.10940821","article-title":"Introducing nephrocardiology","volume":"17","author":"Hatamizadeh","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2024.05.081_bib8","first-page":"295","article-title":"Introduction to nephrocardiology","volume":"39","author":"Hatamizadeh","year":"2021","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jacc.2024.05.081_bib9","series-title":"2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2023"},{"key":"10.1016\/j.jacc.2024.05.081_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1540-8159.2007.00677.x","article-title":"Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients","volume":"30","author":"Chen-Scarabelli","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1540-8159.2007.00651.x","article-title":"Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death","volume":"30","author":"Cuculich","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100639","article-title":"Implantable cardioverter defibrillators and chronic kidney disease","volume":"46","author":"Kiage","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamainternmed.2017.8462","article-title":"Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease","volume":"178","author":"Bansal","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2024.05.081_bib15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib16","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.hrthm.2022.06.030","article-title":"The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator","volume":"19","author":"Gasperetti","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.05.081_bib17","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa2300080","article-title":"A\u00a0dual-chamber leadless pacemaker","volume":"388","author":"Knops","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib18","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","article-title":"Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) study","volume":"59","author":"Hsu","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib19","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ejhf.2524","article-title":"The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HF","volume":"24","author":"Cleland","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.05.081_bib20","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2215\/CJN.00620115","article-title":"Cardiac resynchronization therapy in CKD stage 4 patients","volume":"10","author":"H\u00f6ke","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2024.05.081_bib21","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.jacc.2015.09.097","article-title":"Comparative effectiveness of CRT-D versus defibrillator alone in hf patients with moderate-to-severe chronic kidney disease","volume":"66","author":"Friedman","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cardfail.2019.07.005","article-title":"Response to cardiac resynchronization therapy across chronic kidney disease stages","volume":"25","author":"Ter Maaten","year":"2019","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.05.081_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/pace.12883","article-title":"The effect of chronic kidney disease on mortality with cardiac resynchronization therapy","volume":"39","author":"Daly","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/eurjhf\/hfs135","article-title":"Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study","volume":"14","author":"Mathew","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.05.081_bib25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/pace.12685","article-title":"Renal response in patients with chronic kidney disease predicts outcome following cardiac resynchronization therapy","volume":"38","author":"Singal","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5603\/CJ.a2015.0019","article-title":"Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy","volume":"22","author":"Gronda","year":"2015","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacc.2024.05.081_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/pace.13823","article-title":"Severe chronic kidney disease is associated with poor survival after initial CRT-defibrillator tachyarrhythmia therapy","volume":"43","author":"Adelstein","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pace.13659","article-title":"Renal function and the long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation","volume":"42","author":"Leyva","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","article-title":"Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study","volume":"30","author":"Pun","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2024.05.081_bib30","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.05.081_bib31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/europace\/euv391","article-title":"Prevalence and predictor factors of severe venous obstruction after cardiovascular electronic device implantation","volume":"18","author":"Santini","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.05.081_bib32","first-page":"686","article-title":"Usefulness of preoperative venography in patients with cardiac implantable electronic devices submitted to lead replacement or device upgrade procedures","volume":"111","author":"Albertini","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.17219\/acem\/42317","article-title":"Venous stenosis and occlusion in the presence of endocardial leads","volume":"25","author":"Boczar","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10016-003-0048-4","article-title":"Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers","volume":"17","author":"Teruya","year":"2003","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2024.05.081_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.ajkd.2013.11.018","article-title":"Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients","volume":"64","author":"Hickson","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2024.05.081_bib36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1525-139X.2012.01053.x","article-title":"Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination","volume":"25","author":"Asif","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.jacc.2024.05.081_bib37","first-page":"1745","article-title":"Cardiac implantable electronic devices in hemodialysis and chronic kidney disease patients\u2014an experience-based narrative review","volume":"10","author":"Nowak","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib38","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.hrthm.2020.04.036","article-title":"Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: results from the S-ICD post-approval study","volume":"17","author":"El-Chami","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.05.081_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10840-018-0343-1","article-title":"Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients","volume":"52","author":"You","year":"2018","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/pace.14411","article-title":"Implantable cardioverter-defibrillators with end stage renal disease: Nationwide inpatient sample database results","volume":"45","author":"Ayoub","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2009.08.006","article-title":"Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation","volume":"6","author":"Aggarwal","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.05.081_bib42","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/ajkd.2001.24527","article-title":"A\u00a0prospective study of vascular access infections at seven outpatient hemodialysis centers","volume":"37","author":"Tokars","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2024.05.081_bib43","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/ndt\/14.12.2807","article-title":"Impaired cellular immune function in patients with end-stage renal failure","volume":"14","author":"Girndt","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2024.05.081_bib44","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.hrthm.2015.08.003","article-title":"Cardiac implantable electronic device infection in patients with end-stage renal disease","volume":"12","author":"Guha","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.05.081_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","article-title":"Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States","volume":"58","author":"Charytan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2024.05.081_bib46","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.hrthm.2015.06.033","article-title":"Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period","volume":"12","author":"Wong","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2024.05.081_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/anec.12119","article-title":"Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator","volume":"19","author":"Wan","year":"2014","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib48","first-page":"4013","article-title":"Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators","volume":"11","author":"Sabbagh","year":"2020","journal-title":"J\u00a0Innov Card Rhythm Manag"},{"key":"10.1016\/j.jacc.2024.05.081_bib49","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/CIRCRESAHA.116.304679","article-title":"Cardiac innervation and sudden cardiac death","volume":"116","author":"Fukuda","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.05.081_bib50","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.RES.0000269828.62250.ab","article-title":"Cardiac sympathetic rejuvenation","volume":"100","author":"Kimura","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.05.081_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2016.04.170","article-title":"Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies","volume":"217","author":"Di Lullo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib52","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1540-8159.1996.tb04215.x","article-title":"Effects of autonomic manipulation on ventricular fibrillation and internal cardiac defibrillation thresholds in pigs","volume":"19","author":"Morillo","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/europace\/eut383","article-title":"The effect of hyperkalaemia on cardiac rhythm devices","volume":"16","author":"Barold","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.05.081_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1540-8159.2007.00567.x","article-title":"Hyperkalemia during cardiac pacing","volume":"30","author":"Barold","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ndt\/gfaa284","article-title":"Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis","volume":"37","author":"Romero-Gonzalez","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2024.05.081_bib56","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.05.081_bib57","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1093\/ndt\/gfm954","article-title":"Decreased coronary flow reserve in haemodialysis patients","volume":"23","author":"Niizuma","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2024.05.081_bib58","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/ckj\/sfu106","article-title":"Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients","volume":"7","author":"Edwards-Richards","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jacc.2024.05.081_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncpneph0655","article-title":"Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure","volume":"4","author":"van der Putten","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.jacc.2024.05.081_bib60","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.05.081_bib61","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-\u03b21 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2024.05.081_bib62","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1006\/jmcc.1997.0435","article-title":"Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts","volume":"29","author":"Campbell","year":"1997","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacc.2024.05.081_bib64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ahj.2014.01.004","article-title":"Scar tissue-guided left ventricular lead placement for cardiac resynchronization therapy in patients with ischemic cardiomyopathy: an acute pressure-volume loop study","volume":"167","author":"de Roest","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.05.081_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1532-429X-13-29","article-title":"Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance","volume":"13","author":"Leyva","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2024.05.081_bib66","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1681\/ASN.V1251079","article-title":"Left ventricular hypertrophy in the renal patient","volume":"12","author":"Middleton","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2024.05.081_bib67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.jacc.2024.05.081_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad059","article-title":"Timing of cardiac resynchronization therapy implantation","volume":"25","author":"Leyva","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.05.081_bib69","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ehjcvp\/pvv016","article-title":"Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival","volume":"1","author":"Witt","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2024.05.081_bib70","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.05.081_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2018.11.098","article-title":"Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the Kailuan study","volume":"277","author":"Guo","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States","volume":"4","author":"Baber","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib73","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2459\/JCM.0000000000001308","article-title":"Renal function and mortality in patients with atrial fibrillation","volume":"23","author":"Liampas","year":"2022","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jacc.2024.05.081_bib74","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.123992","article-title":"Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease","volume":"127","author":"Bansal","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.05.081_bib75","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.05.081_bib76","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/jce.12554","article-title":"The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis","volume":"26","author":"Chen","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib77","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacc.2024.05.081_bib78","article-title":"Atrial fibrillation is associated with higher overall mortality in patients with implantable cardioverter-defibrillator: a systematic review and meta-analysis","volume":"7","author":"Mustafa","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.05.081_bib79","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2008.06.043","article-title":"Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"52","author":"Upadhyay","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jchf.2019.02.009","article-title":"Medical management of heart failure with reduced ejection fraction in patients with advanced renal disease","volume":"7","author":"Hein","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2024.05.081_bib81","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ahj.2007.03.017","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease","volume":"153","author":"Berger","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.05.081_bib82","first-page":"41","article-title":"The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease","volume":"24","author":"Dounaevskaia","year":"2011","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jacc.2024.05.081_bib83","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jacep.2022.05.001","article-title":"Guideline-directed medical therapy and the risk of death in primary prevention defibrillator recipients","volume":"8","author":"Dhande","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ahj.2010.09.020","article-title":"Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease","volume":"161","author":"Alsheikh-Ali","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.05.081_bib85","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/ecr.2021.25","article-title":"Valvular heart disease in patients with chronic kidney disease","volume":"17","author":"Kipourou","year":"2022","journal-title":"Eur Cardiol"},{"issue":"18","key":"10.1016\/j.jacc.2024.05.081_bib86","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.3390\/nu14183848","article-title":"Nutritional predictors of mortality after 10 years of follow-up in patients with chronic kidney disease at a multidisciplinary unit of advanced chronic kidney disease","volume":"14","author":"Barril","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jacc.2024.05.081_bib87","first-page":"547","article-title":"Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study","volume":"22","author":"Chan","year":"2012","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.jacc.2024.05.081_bib88","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"De Jager","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.05.081_bib89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrneph.2014.8","article-title":"Noncardiovascular mortality in CKD: an epidemiological perspective","volume":"10","author":"de Jager","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2024.05.081_bib90","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib91","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2006.03.025","article-title":"Relations among renal function, risk of sudden cardiac death, and benefit of the implanted with ischemic left cardiac defibrillator in patients ventricular dysfunction","volume":"98","author":"Goldenberg","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib92","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib93","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib94","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib95","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy","volume":"105","author":"B\u00e4Nsch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.05.081_bib96","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib97","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib98","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.05.081_bib99","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure","volume":"289","author":"Young","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.05.081_bib100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib101","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.05.081_bib102","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","article-title":"Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart\u00a0Failure (COMPANION) Trial","volume":"114","author":"Saxon","year":"2006","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724080367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724080367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:15:54Z","timestamp":1759349754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724080367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":102,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0735109724080367"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.05.081","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable Cardioverter Defibrillator and\u00a0Resynchronization Therapy in\u00a0Patients With Overt Chronic Kidney\u00a0Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.05.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}